Thailand to sell generic Viagra drug: officials

September 26, 2012

Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.

The Thai diamond-shaped little blue pill, which resembles the original produced by US pharmaceutical giant , is called "Sidegra" and will be available on prescription across the country on October 1.

Priced at 25 baht (80 US cents) per pill, Thailand's (FDA) said it will be ten times cheaper than full-price Viagra.

"This measure will solve widespread production of by increasing accessibility to the legal version," FDA secretary general Pipat Yingseree said in a statement.

The release said Pfizer had since looked to discount its pills by 30 percent to "cooperate with the government on curbing fake drugs".

"Pfizer is selling at a discount to be able to compete with our Sidegra," said an official at the state-run Government Pharmaceutical Organisation, which is producing the drug.

No one from Pfizer's offices in Thailand was available for comment.

An FDA official said the US company's patent to produce the anti-impotence had expired in Thailand.

Fake sex drugs are openly on sale on street stalls targeting tourists around the red light districts of the Thai capital.

In a raid on a Bangkok warehouse in July, Thai police seized several hundred thousand purported sex enhancement and aphrodisiac pills and a large haul of sex toys, worth an estimated $3.2 million.

Explore further: S. Korea to approve Viagra generics

Related Stories

S. Korea to approve Viagra generics

March 14, 2012
Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.

Internet led to global 'explosion' of fake drugs

June 14, 2012
The rapid growth of Internet commerce has led to an explosion of counterfeit drugs sold around the world, with China the biggest source of fake medicines, pharmaceutical experts said Thursday.

US approves India's Ranbaxy to make generic Lipitor

December 1, 2011
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.

China arrests nearly 2,000 in fake drug crackdown

August 6, 2012
(AP) — China's Ministry of Public Security says it has detained nearly 2,000 people in a nationwide crackdown on counterfeit drugs, including some to treat cancer.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.